학술논문
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
Document Type
Article
Author
Source
In: BMC Cancer . (BMC Cancer, December 2023, 23(1))
Subject
Language
English
ISSN
14712407